| KMT2D altered in cohorts of …ALTERED_INderived33 of 33show fewer |
|---|
| → altered in cohorts of | Adrenal Cortical Carcinoma 69 / 92 cases (75 %) · ssm · TCGA-ACC | — | — | Adrenal Cortical Carcinoma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 61 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Pelvis and Ureter Urothelial Carcinoma 41 / 119 cases (34 %) · ssm · utuc_msk_2019 · largest of 3 cohorts | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 247 / 755 cases (33 %) · ssm · mbn_mdacc_2013 · largest of 3 cohorts | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 139 / 474 cases (29 %) · ssm · blca_msk_tcga_2020 · largest of 13 cohorts | — | — | Bladder Urothelial Carcinoma | 13 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 46 / 158 cases (29 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 61 / 247 cases (25 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Large B-Cell Lymphoma Unclassifiable 247 / 1,001 cases (25 %) · ssm · dlbcl_duke_2017 · largest of 2 cohorts | — | — | Diffuse Large B-Cell Lymphoma Unclassifiable | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 165 / 696 cases (24 %) · ssm · mel_mskimpact_2020 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Primary Central Nervous System Lymphoma 20 / 86 cases (23 %) · ssm · pcnsl_msk_2024 | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 111 / 484 cases (23 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 22 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Squamous Cell Carcinoma 25 / 139 cases (18 %) · ssm · escc_ucla_2014 | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 91 / 518 cases (18 %) · ssm · stes_tcga_pub · largest of 3 cohorts | — | — | Gastroesophageal Junction Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 32 / 185 cases (17 %) · ssm · esca_tcga · largest of 3 cohorts | — | — | Esophageal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 77 / 515 cases (15 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 69 / 478 cases (14 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 163 / 1,144 cases (14 %) · ssm · nsclc_tcga_broad_2016 · largest of 5 cohorts | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 41 / 291 cases (14 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 58 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 231 / 1,882 cases (12 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 8 cohorts | — | — | Endometrial Carcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 805 / 7,237 cases (11 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Adenoid Cystic Carcinoma 111 / 1,049 cases (11 %) · ssm · acc_2019 | — | — | Adenoid Cystic Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 107 / 1,134 cases (9.4 %) · ssm · crc_msk_2017 · largest of 5 cohorts | — | — | Colorectal Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 176 / 2,433 cases (7.2 %) · ssm · brca_metabric · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 30 / 417 cases (7.2 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Medulloblastoma 34 / 491 cases (6.9 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Myelodysplastic Syndrome 224 / 3,323 cases (6.7 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 133 / 2,069 cases (6.4 %) · ssm · prad_msk_stopsack_2021 · largest of 9 cohorts | — | — | Prostate Adenocarcinoma | 9 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 167 / 2,653 cases (6.3 %) · ssm · luad_mskcc_2023_met_organotropism · largest of 3 cohorts | — | — | Lung Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 39 / 629 cases (6.2 %) · ssm · difg_glass · largest of 2 cohorts | — | — | Diffuse Glioma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |